
Lifera is a biopharmaceutical company focused on developing and manufacturing the medicines of tomorrow. As a biomanufacturing and innovation partner, Lifera aims to improve Saudi Arabia’s biopharma resilience and enable the goals of the Saudi National Biotechnology Strategy. They are developing state-of-the-art biomanufacturing capacity for drug substance and drug product manufacturing, including sterile and aseptic filling for vials, pre-filled syringes, and cartridges. Additionally, Lifera is building at-scale multiomics capabilities for high-throughput genetic testing and research services, with a focus on bioinformatics for disease areas endemic to MENA populations. The company serves pharmaceutical and biotech customers globally, bridging the KSA market with exports and enabling AI drug discovery. Lifera's strategy involves becoming a leading Contract Development and Manufacturing Organization (CDMO) for advanced therapeutics and critical medicines.

Lifera is a biopharmaceutical company focused on developing and manufacturing the medicines of tomorrow. As a biomanufacturing and innovation partner, Lifera aims to improve Saudi Arabia’s biopharma resilience and enable the goals of the Saudi National Biotechnology Strategy. They are developing state-of-the-art biomanufacturing capacity for drug substance and drug product manufacturing, including sterile and aseptic filling for vials, pre-filled syringes, and cartridges. Additionally, Lifera is building at-scale multiomics capabilities for high-throughput genetic testing and research services, with a focus on bioinformatics for disease areas endemic to MENA populations. The company serves pharmaceutical and biotech customers globally, bridging the KSA market with exports and enabling AI drug discovery. Lifera's strategy involves becoming a leading Contract Development and Manufacturing Organization (CDMO) for advanced therapeutics and critical medicines.